2020 / 04

Next Paper
DOI: 10.47183/mes.2020.024

REVIEW

Endothelial dysfunction in COVID-19 patients and clinical application of laser therapy

Kochetkov AV1,2, Ponomareva NYu2, Kadnikova NG2, Mitkovskij VG1,2, Yampolskaya EN2, Lazarev VV2
About authors

1 Academy of Postgraduate Education FNSC FMBA of Russia, Moscow, Russia

2 Central Clinical Hospital for the Rehabilitation of FMBA of Russia, Solnechnogorsk District, Moscow Region, Russia

Correspondence should be addressed: Andrey V. Kochetkov
Volokolamskoe shosse, 91, Moscow, 125371; ur.xobni@voktehctok

About paper

Author contribution: AV Kochetkov — idea, data analysis and interpretation; NYu Ponomareva — literature analysis, manuscript drafting; NG Kadnikova — laser therapy technique application, data collection; VG Mitkovskij — research organization task setting; EN Yampolskaya — research results analysis and interpretation; VV Lazarev — selection of patients for application of the technique, analysis of the results.

Received: 2020-11-09 Accepted: 2020-11-24 Published online: 2020-12-19
|
  1. Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020; 24 (1): 353. DOI: 10.1186/s13054- 020-03062-7.
  2. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020; 383 (2): 120–28. DOI: 10.1056/NEJMoa2015432.
  3. Suchkov IA. Korrekcija jendotelial'noj disfunkcii: sovremennoe sostojanie problemy (obzor literatury). Rossijskij mediko-biologicheskij vestnik imeni akademika I. P. Pavlova. 2012; 20 (4): 151–57. Russian.
  4. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288 (5789): 373–76.
  5. Aleksandrov AA. Baza znanij po biologii cheloveka. Razdel narushenija funkcii jendotelija i serdechno-sosudistye zabolevanija. Dostupno po ssylke: https://humbio.ru/humbio/car_g/000b1acc. htm. Russian.
  6. The Human Genome Project (HGP). Available from: https://www. genome.gov/human-genome-project.
  7. The 1000 Genomes Project Consortium. Erratum: A map of human genome variation from population-scale sequencing. Nature. 2011; 473: 544. Available from: https://doi.org/10.1038/ nature09991.
  8. O'Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med. 2011; 365 (22): 2098–09. DOI: 10.1056/ NEJMra1105239.
  9. Roberts R, Marian AJ, Dandona S, Stewart AF. Genomics in cardiovascular disease. J Am Coll Cardiol. 2013; 61 (20): 2029– 37. DOI: 10.1016/j.jacc.2012.12.054.
  10. Online Mendelian Inheritance in Man® An Online Catalog of Human Genes and Genetic Disorders. Available from: h t t p s : / / w w w. omim.org.
  11. The National Center for Biotechnology Information. Available from: https://www.ncbi.nlm.nih.gov/variation/news/NCBI_retiring_HapMap.
  12. Torshin IYu, Gromova OA. Sosudistye zabolevanija serdca, mozga i molekuljarnye geny. Associativnye issledovanija i patofiziologija sosudistyh zabolevanij. Trudnyj pacient. 2008; 2–3. Available from: https://cyberleninka.ru/article/n/sosudistye-zabolevaniya-serdtsa-mozga-i-molekulyarnye-geny-assotsiativnye-issledovaniya-i-patofiziologiya-sosudistyh-zabolevaniy. Russian.
  13. Kirichuk VF, Glybochko PV, Ponomareva AI. Disfunkcija jendotelija. Saratov: Izd-vo Saratovskogo GMU, 2008; 129 s. Russian.
  14. Levickij SN. Geneticheskie markery jendotelinovoj sistemy v uspeshnosti vypolnenija kognitivnyh zadach. Dostupno po ssylke: http://scienceforum.ru/2017/article/2017037479. Russian.
  15. Moroz VV, Smirnova SG, Ivanova OV, Poroshenko GG. Mutacii i antimutageny v medicine kriticheskih sostojanij. Obshhaja reanimatologija. 2007; 3 (5–6): 213–7. Russian.
  16. Moroz VV, Vlasenko AV, Golubev AM, Jakovlev VN, Alekseev VG, Bulatov N. N., Smelaja T. V. Patogenez i differencial'naja diagnostika respiratornogo distress sindroma. Obshhaja reanimatologija. 2011; 7 (3): 5–13. Russian.
  17. Moroz VV, Smelaja TV, Golubev AM, Salnikova LE. Genetika i medicina kriticheskih sostojanij: ot teorii k praktike. Obshhaja reanimatologija. 2012; 7 (4): 5–12. Russian.
  18. Salnikova LE, Smelaya TV, Moroz VV, Golubev AM, Rubanovich AV. Functional polymorphisms in the CYP1A1, ACE, and IL-6 genes contribute to susceptibility to community-acquired and nosocomial pneumonia. International Journal of Infectious Diseases. 2013; Feb 11: 119–24.
  19. Nazarenko GI, Klejmenova EB, Gushhina NN. Izuchenie geneticheskih markerov i tradicionnyh faktorov riska razvitija ishemicheskoj bolezni serdca. Ros. med. vesti. 2009; 14 (1): 47– 54. Russian.
  20. Genetika cheloveka: test-sistemy dlja PCR-diagnostiki. Katalog produkcii. Nauchno-proizvodstvennaja firma Laboratorija «Liteh». 2020, 38 s. Dostupno po ssylke: http://lytech.ru/upload/medialibrary/ lytpdf/Catalog_genetics_2020_02_26.pdf.
  21. Ponomareva NYu, Mitkovskij VG, Jampolskaja EN, Kochetkov AV. Ispol'zovanie innovacionnyh podhodov personificirovannoj mediciny i genotipirovanija v medicinskoj reabilitacii. V sbornike: Materialy Nauchno-prakticheskoj Konferencii «Aktual'nye voprosy medicinskoj reabilitacii» v MC «Reshma». Nauchno-prakticheskij zhurnal «Kurortnaja medicina». 2016; 2: 119–21. Russian.
  22. Ponomareva NYu, Mitkovskij VG, Jampolskaja EN, Kochetkov AV, Nalbandjan N. G. Genotipirovanie kak novoe sredstvo diagnostiki, profilaktiki i individual'noj terapii narushenij svertyvajushhej sistemy krovi. V sbornike: Materialy 3-go Vsemirnogo Kongressa “Controversies in Thrombosis and Hemostasis (CiTH)” sovmestno s 8-j Vserossijskoj konferenciej po klinicheskoj gemostaziologii i gemoreologii. Tromboz, gemostaz i reologija. M., 2016; 3 (1): 337–38. Russian.
  23. Ponomareva NYu, Mitkovskij VG, Jampolskaja EN, Kochetkov AV. Geneticheskie issledovanija dlja mediciny jekstremal'nyh situacij. Medicina jekstremal'nyh situacij. 2017; 4: 63–74. Russian.
  24. Ponomareva NYu, Kochetkov AV, Mitkovskij VG, Jampolskaja EN. Integracija personificirovannyh podhodov v praktiku vosstanovitel'noj mediciny: ot diagnostiki k lecheniju i reabilitacii. V sbornike: Materialy III Mezhdunarodnogo kongressa «Fizioterapija. Lechebnaja fizkul'tura. Reabilitacija. Sportivnaja medicina», 2017; 112. Dostupno po ssylke: http://www.rehabcongress.ru. Russian.
  25. Ponomareva NYu, Mitkovskij VG, Jampolskaja EN, Kochetkov AV. Geneticheskoe obsledovanie i personificirovannoj podhod v zdorov'esberezhenii, preventivnoj i vosstanovitel'noj medicine. V sbornike: Materialy Konferencii HII Vserossijskogo foruma Vystavki i Kongressa «Zdorov'e nacii — osnova procvetanija Rossii» 2018; 36–43. Russian.
  26. Baranov VS. Genom cheloveka, «nedostajushhaja» nasledstvennost' i geneticheskij pasport. Medicinskaja genetika. 2011; 9: 3–10.
  27. Kolchanov NA, Podkolodnaja AO, Ignateva EV, i dr. Integracija gennyh setej, kontrolirujushhih fiziologicheskie funkcii organizma. Vestnik VOGIS. 2005; 9 (2): 179–199. Russian.
  28. Kochetkov AV. Lechebnye fizicheskie faktory na jetape rannej reabilitacii bol'nyh cerebral'nym insul'tom [dissertacija]. M., 1998. Russian.
  29. Daulatzai MA. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease. J Neurosci Res. 2017; 95 (4): 943–72. DOI: 10.1002/ jnr.23777.
  30. Grigorev NB, Granik VG. Oksid azota (NO). Novyj put' k poisku lekarstv. M.: Vuzovskaja kniga, 2004; 360 s. Russian.
  31. Krupatkin AI, Sidorov VV. Lazernaja dopplerovskaja floumetrija mikrocirkuljacii krovi. M.: Medicina, 2005; 256 s. Russian.
  32. Moskvin SV, Ryzhova TV. Lazernaja terapija v jendokrinologii. Serija «Jeffektivnaja lazernaja terapija». T. 5. Tver': Triada, 2020; 1024 s. Russian.
  33. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54 (6): 1615–25. DOI: 10.2337/diabetes.54.6.1615.
  34. Shvalb PG, Kalinin RE, Kachinskij AE. Konservativnoe lechenie zabolevanij perifericheskih sosudov. Rjazan': Poligrafkombinat «Tigel'», 2008; 91 s. Russian.
  35. Moskvin SV. Lazernaja terapija v dermatologii: vitiligo. M.: Tehnika, 2003; 125 s. Russian.
  36. Moskvin SV. Sistemnyj analiz jeffektivnosti upravlenija biologicheskimi sistemami nizkojenergeticheskim lazernym izlucheniem [dissertacija]. Tula, 2008. Russian.
  37. Moskvin SV. Jeffektivnost' lazernoj terapii. Serija «Jeffektivnaja lazernaja terapija». T. 2. Tver': Triada, 2014; 896 s. Russian.
  38. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007; 115 (10): 1285–95. DOI: 10.1161/CIRCULATIONAHA.106.652859.
  39. Shimokawa H. Godo S, Shimokawa H. Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis. Free Radic Biol Med. 2017; 109: 4–10. DOI: 10.1016/j.freeradbiomed.2016.12.019.
  40. Murrey RK, Granner DK, Mayes PA, Rodwell VW. Harper’s biochemistry. Appleton & Lange: 1996, 700 r.
  41. Bpill GE, Bpill AG. Guanilatciklaza i NO-sintetaza — vozmozhnye pervichnye akceptory jenergii nizkointensivnogo lazernogo izluchenija. Lazernaja medicina. 1997; 1 (2): 39–42. Russian.
  42. Ankri R, Friedman H, Savion N et al. Visible light induces nitric oxide (NO) formation in sperm and endothelial cells. Lasers in Surgery and Medicine. 2010; 2 (4): 348–52. DOI: 10.1002/ lsm.20849.
  43. Dabbous OA, Soliman MM, Mohamed NH, et al. Evaluation of the improvement effect of laser acupuncture biostimulation in asthmatic children by exhaled inflammatory biomarker level of nitric oxide. Lasers in Medical Science. 2017; 32 (1): 53–59. DOI: 10.1007/s10103-016-2082-9.
  44. Eshaghi E, Sadigh-Eteghad S, Mohaddes G, Rasta SH. Transcranial photobiomodulation prevents anxiety and depression via changing serotonin and nitric oxide levels in brain of depression model mice: A study of three different doses of 810 nm laser. Lasers in Surgery and Medicine. 2019; 51 (7): 634–42. DOI: 10.1002/lsm.23082.
  45. Houreld NN, Sekhejane PR, Abrahamse H. Irradiation at 830 nm stimulates nitric oxide production and inhibits pro-inflammatory cytokines in diabetic wounded fibroblast cells. Lasers in Surgery and Medicine. 2010; 42 (6): 494–502. DOI: 10.1002/lsm.20812.
  46. Karu TI, Pyatibrat LV, Afanasyeva NI. Cellular effects of low power laser therapy can be mediated by nitric oxide. Lasers in Surgery and Medicine. 2005; 36 (4): 307–14. DOI: 10.1002/lsm.20148.
  47. Rizzi M, Migliario M, Tonello S, et al. Photobiomodulation induces in vitro re-epithelialization via nitric oxide production. Lasers in Medical Science. 2018; 33 (5): 1003–8. DOI: 10.1007/s10103- 018-2443-7.
  48. Gorshkova OP, Shuvaeva VN, Dvoreckij DP. Reakcii pial'nyh arterial'nyh sosudov na vozdejstvie nizkointensivnogo lazernogo izluchenija sinej i zelenoj oblastej spektra. Regionarnoe krovoobrashhenie i mikrocirkuljacija. 2013; 12 (3): 71–74. DOI: 10.24884/1682-6655-2013-12-3-71-74. Russian.
  49. Amaroli A, Benedicenti A, Ferrando S et al. Photobiomodulation by infrared diode laser: effects on intracellular calcium concentration and nitric oxide production of paramecium. Photochemistry and Photobiology. 2016; 92 (6): 854–62. DOI: 10.1111/php.12644.
  50. Gorshkova OP, Shuvaeva VN, Dvoretsky DP. Role of nitric oxide in responses of pial arterial vessels to low-intensity red laser irradiation. Bull Exp Biol Med. 2013; 155 (5): 598–600. DOI: 10.1007/s10517-013-2203-4.
  51. Glazova TG, Ryvkin AI, Pobedinskaja NS, Larjushkina RM. Analiz jeffektivnosti razlichnyh terapevticheskih kompleksov pri bronhial'noj astme u detej. Vestnik Ivanovskoj medicinskoj akademii. 2013; 18 (4): 56–57. Russian.
  52. Glazova TG, Ryvkin AI, Larjushkina RM, i dr. Nizkointensivnoe lazernoe izluchenie v reabilitacii detej s bronhial'noj astmoj. Vestnik Ivanovskoj medicinskoj akademii. 2016; 21 (1): 56–60. Russian.
  53. Barberis G, Gamron S, Acevedo G et al. In vitro release of prostaglandin E2 after helium-neon laser radiation from synovial tissue in osteoarthritis. Journal of Clinical Laser Medicine & Surgery. 1995; 13 (4): 263–65. DOI: 10.1089/clm.1995.13.263.
  54. Campana VR, Castel A, Vidal AE et al. Prostaglandin E2 in experimental arthritis of rats irradiated with He-Ne laser. Journal of Clinical Laser Medicine & Surgery. 1993; 11 (2): 79–81. DOI: 10.1089/clm.1993.11.79.
  55. Kwon H, Lim WB, Kim JS, et al. Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells. Lasers in Medical Science. 2013; 28 (3): 717– 24. DOI: 10.1007/s10103-012-1122-3.
  56. Burduli NM, Tadtaeva DYa. Vlijanie vnutrivennoj lazernoj terapii na dinamiku prostaglandinov E2 i F2a i sostojanie mikrocirkuljacii u bol'nyh, stradajushhih gastrojezofageal'noj refljuksnoj bolezn'ju. Voprosy kurortologii, fizioterapii i LFK. 2012; 6: 17–20. Russian.
  57. Zasorina MA. Kombinirovannoe konservativnoe lechenie hronicheskoj kriticheskoj ishemii nizhnih konechnostej v uslovijah neoperabel'nogo porazhenija arterial'nogo rusla [dissertacija]. M., 2005. Russian.
  58. Ishpahtin YuI. Aktual'nye problemy ginekologii detskogo vozrasta. Vladivostok: Izd-vo Dal'nevost. federal'nogo un-ta, 2015; 216 s. Russian.
  59. Krysjuk OB. Personalizirovannaja lazeroterapija bol'nyh gipertonicheskoj bolezn'ju i ishemicheskoj bolezn'ju serdca [dissertacija]. SPb., 2006. Russian.
  60. Stupnickij AA. Magnitolazernaja terapija v kompleksnom lechenii bol'nyh gipertonicheskoj bolezn'ju [dissertacija]. SPb., 2004. Russian.
  61. Chubarova OG. Vlijanie kvinaprila (akkupro) i kvantovoj gemoterapii na klinicheskoe techenie arterial'noj gipertenzii i metabolicheskogo sindroma [dissertacija]. M., 2004. Russian.
  62. Zavalej EG. Vlijanie opticheskogo izluchenija ul'trafioletovogo, vidimogo i infrakrasnogo diapazonov na osnovnye komponenty kallikrein-kininovoj sistemy krovi, serotonin, gistamin v dializatah kozhi u bol'nyh hronicheskim bronhitom [dissertacija]. M., 1987. Russian.
  63. Nejmark MI, Kalinin AP. Jekstrakorporal'naja gemokorrekcija v jendokrinnoj hirurgii. M.: Medkniga, 2007; 205. Russian.
  64. Proskurjakov VV. Perekisnoe okislenie lipidov i gemostaz, puti korrekcii ih narushenij u bol'nyh bronhial'noj astmoj [dissertacija]. Perm, 1995; 21. Russian.
  65. Chikisheva IV. Jeffektivnost' nizkointensivnogo lazernogo izluchenija u bol'nyh infekcionno-allergicheskoj formoj bronhial'noj astmy [dissertacija]. Harkov, 1987. Russian.
  66. Moskvin SV, Ashadulin EV, Kondrateva MS. Opyt primenenija lazernoj terapii v reabilitacii bol'nyh COVID-19. Vestnik novyh medicinskih tehnologij. Jelektronnoe periodicheskoe izdanie. 2020; (4): Publikacija 3–2. Dostupno po ssylke: http://www.medtsu.tula. ru/VNMT/Bulletin/E2020-4/3-2.pdf. DOI: 10.24411/2075-4094- 2020-16697. Russian.
  67. Ashadulin EV, Konchugova TV, Moskvin SV. Kombinirovannaja lazernaja terapija v lechenii pacientov s troficheskimi jazvami nizhnih konechnostej. Voprosy kurortologii, fizioterapii i LFK. 2018; 95 (6): 27–33. DOI: 10.17116/kurort20189506127. Russian.
  68. Kochetkov AV, Moskvin SV. Lazernaja terapija bol'nyh cerebral'nym insul'tom. Tver: Triada, 2004; 51 s. Russian.
  69. Kochetkov AV, Moskvin SV, Karneev AN. Lazernaja terapija v nevrologii. Tver: Triada, 2012; 360 s. Russian.
  70. Anackaja LN, Goncharova NV, Severin IN, i dr. Vlijanie vnutrivennogo lazernogo obluchenija krovi na uroven' cirkulirujushhih jendotelial'nyh kletok-predshestvennic v ostrom periode lakunarnyh infarktov mozga. Izvestija Nacional'noj akademii nauk Belarusi. Serija medicinskih nauk. 2015; 3: 24–29. Russian.
  71. Belov VV, Harlamova UV. Ocenka vlijanija vnutrivennoj lazeroterapii na biohimicheskie pokazateli, tolerantnost' k fizicheskoj nagruzke v zavisimosti ot klassa tjazhesti nestabil'noj stenokardii. Vestnik Juzhno-Ural'skogo gosudarstvennogo universiteta. Serija: Obrazovanie, zdravoohranenie, fizicheskaja kul'tura. 2005; 1 (5): 313–15. Russian.
  72. Belov VV, Harlamova UV. Ocenka faktorov jeffektivnosti nizkointensivnogo lazernogo izluchenija u bol'nyh nestabil'noj stenokardiej. Rossijskij kardiologicheskij zhurnal. 2008; 72 (4): 16–19. Russian.
  73. Burduli NM, Gireeva EYu. Vlijanie vnutrivennogo lazernogo obluchenija krovi na funkciju jendotelija u bol'nyh stabil'noj stenokardiej. Vestnik novyh medicinskih tehnologij. 2009; 16 (4): 101–02. Russian.
  74. Burduli NM, Krifaridi AS. Vlijanie nizkointensivnoj lazernoj terapii na disfunkciju jendotelija u bol'nyh hronicheskimi virusnymi gepatitami. Mezhdunarodnyj zhurnal serdca i sosudistyh zabolevanij. 2014; 2 (3): 11. Russian.
  75. Burduli NM, Krifaridi AS, Aksenova IZ. Patogeneticheskie aspekty primenenija lazernogo izluchenija. Nauchnye vedomosti. Serija: Medicina. Farmacija. 2019; 42 (1): 5–12. DOI: 10.18413/2075- 4728-2019-42-1-5-12. Russian.
  76. Gireeva EYu. Dinamika pokazatelej gomocisteina, funkcii jendotelija, processov perekisnogo okislenija lipidov i gemostaza u bol'nyh stabil'noj stenokardiej pod vlijaniem nizkointensivnogo lazernogo izluchenija [dissertacija]. Vladikavkaz, 2010; 25 s. Russian.
  77. Burduli NM, Gabueva AA. Korrekcija jendotelial'noj disfunkcii u bol'nyh vnebol'nichnoj pnevmoniej s pomoshh'ju nizkointensivnogo lazernogo obluchenija krovi. Pul'monologija. 2015; 25 (2): 196–8. DOI: 10.18093/0869-0189-2015-25-2-196-198. Russian.
  78. Moskvin SV, Konchugova TV, Hadarcev AA. Osnovnye terapevticheskie metodiki lazernogo osvechivanija krovi. Voprosy kurortologii, fizioterapii i LFK. 2017; 94 (5): 10–17. DOI: 10.17116/ kurort201794510-17. Russian.
  79. Kulova LA, Burduli NM. Vlijanie nizkointensivnogo lazernogo izluchenija na disfunkciju jendotelija i sostojanie mikrocirkuljatornogo rusla u bol'nyh revmatoidnym artritom. Mezhdunarodnyj zhurnal serdca i sosudistyh zabolevanij. 2014; 2 (3): 44–45. Russian.
  80. Moskvin SV, Hadarcev AA. KVCh-lazernaja terapija. Tver: Triada, 2016; 168 s. Russian.
  81. Mokmeli S, Vetrici M. Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19. Canadian Journal of Respiratory Therapy. 2020; 56: 25–31. DOI: 10.29390/cjrt-2019-015.
  82. Thevarajan I, Nguyen THO, Koutsakos M, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nature Medicine. 2020; DOI: 10.1038/s41591-020-0819-2